Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Class H 01349
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 2.12
- Day Range
- HKD 2.12–2.18
- 52-Week Range
- HKD 2.03–3.19
- Bid/Ask
- HKD 2.17 / HKD 2.18
- Market Cap
- HKD 2.26 Bil
- Volume/Avg
- 1.0 Mil / 656,536
Key Statistics
- Price/Earnings (Normalized)
- 11.21
- Price/Sales
- 2.38
- Dividend Yield (Trailing)
- 3.68%
- Dividend Yield (Forward)
- 3.68%
- Total Yield
- 3.68%
Company Profile
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 948
- Website
- http://www.fd-zj.com
Comparables
Valuation
|
Metric
|
01349
|
688553
|
688192
|
|---|---|---|---|
Price/Earnings (Normalized) | 11.21 | 121.33 | — |
Price/Book Value | 0.87 | 1.49 | 15.77 |
Price/Sales | 2.38 | 5.94 | 424.47 |
Price/Cash Flow | 28.55 | — | — |
Price/Earnings
01349
688553
688192
Financial Strength
|
Metric
|
01349
|
688553
|
688192
|
|---|---|---|---|
Quick Ratio | 3.33 | 3.36 | 1.83 |
Current Ratio | 3.42 | 3.63 | 2.06 |
Interest Coverage | 146.67 | 5.52 | −188.34 |
Quick Ratio
01349
688553
688192
Profitability
|
Metric
|
01349
|
688553
|
688192
|
|---|---|---|---|
Return on Assets (Normalized) | 6.51% | 0.97% | −56.72% |
Return on Equity (Normalized) | 8.43% | 1.14% | −70.74% |
Return on Invested Capital (Normalized) | 7.73% | 0.30% | −64.78% |
Return on Assets
01349
688553
688192
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Cswzczjhd | Yrngy | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Dyvvxswprq | Hktjgb | $70.8 Bil | |
HLN
| Haleon PLC ADR | Zhdkmwdlj | Fsh | $38.2 Bil | |
VTRS
| Viatris Inc | Jklwckqf | Bchxn | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Pvhnksf | Rvs | $12.5 Bil | |
CTLT
| Catalent Inc | Bldtpbbnq | Lyycd | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Ypnsrrnfy | Vnsw | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Nplsfddt | Mqlj | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Bfmmxbgy | Jbxzq | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Xvxbtzggx | Kvjk | $2.9 Bil |